Literature DB >> 16978811

Conformational polymorphism in bicalutamide.

Daniel R Vega1, Griselda Polla, Andrea Martinez, Elsa Mendioroz, María Reinoso.   

Abstract

Two crystalline forms (forms I and II) and an amorphous phase of bicalutamide were fully characterized through combined results of differential scanning calorimetry, X-ray powder and single crystal diffraction and Raman spectroscopy. Each polymorph crystallizes with one molecule in the asymmetric unit and the molecular conformations are quite different between them. The main difference is provided by C12-C11-S8-C5 torsion angle, which assumes a value of -88.3(4) degrees (-Syn-Clinal) and 72.5(4) degrees (+Syn-Clinal) in forms I and II, respectively. Consequently, molecules in form I show an open folding and molecules in form II a closed one. The relative stability between forms I and II is presented in an energy versus temperature diagram, where forms I and II are considered as a monotropic system, being form I the more stable one. The amorphous phase was observed very metastable and it converts to form II spontaneously at RT in around a week.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16978811     DOI: 10.1016/j.ijpharm.2006.08.001

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  6 in total

1.  Binding of a cyano- and fluoro-containing drug bicalutamide to cytochrome P450 46A1: unusual features and spectral response.

Authors:  Natalia Mast; Wenchao Zheng; C David Stout; Irina A Pikuleva
Journal:  J Biol Chem       Date:  2013-01-03       Impact factor: 5.157

2.  Secretion patterns of circulating osteoprotegerin and response to acute and chronic energy deprivation in young healthy adults.

Authors:  Konstantinos N Aronis; Joo-Pin Foo; John P Chamberland; Christos S Mantzoros
Journal:  J Clin Endocrinol Metab       Date:  2012-05-04       Impact factor: 5.958

3.  Compression-Induced Phase Transitions of Bicalutamide.

Authors:  Joanna Szafraniec-Szczęsny; Agata Antosik-Rogóż; Justyna Knapik-Kowalczuk; Mateusz Kurek; Ewa Szefer; Karolina Gawlak; Krzysztof Chmiel; Sebastian Peralta; Krzysztof Niwiński; Krzysztof Pielichowski; Marian Paluch; Renata Jachowicz
Journal:  Pharmaceutics       Date:  2020-05-09       Impact factor: 6.321

4.  Molecular Disorder of Bicalutamide-Amorphous Solid Dispersions Obtained by Solvent Methods.

Authors:  Joanna Szafraniec; Agata Antosik; Justyna Knapik-Kowalczuk; Karolina Gawlak; Mateusz Kurek; Jakub Szlęk; Witold Jamróz; Marian Paluch; Renata Jachowicz
Journal:  Pharmaceutics       Date:  2018-10-18       Impact factor: 6.321

5.  Charge density view on bicalutamide molecular interactions in the monoclinic polymorph and androgen receptor binding pocket.

Authors:  Alexander A Korlyukov; Maura Malinska; Anna V Vologzhanina; Mikhail S Goizman; Damian Trzybinski; Krzysztof Wozniak
Journal:  IUCrJ       Date:  2020-01-01       Impact factor: 4.769

6.  Physicochemical Profile of Antiandrogen Drug Bicalutamide: Solubility, Distribution, Permeability.

Authors:  Tatyana V Volkova; Olga R Simonova; German L Perlovich
Journal:  Pharmaceutics       Date:  2022-03-18       Impact factor: 6.321

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.